Patient enrolment begins in PARTNERS trial to identify the first effective treatments for Bundibugyo ebolavirus disease
2 July 2026
Patient enrolment has begun in the Democratic Republic of the Congo for the PARTNERS clinical trial of treatments for Bundibugyo virus disease (BVD), an international collaboration between the Institut National de Recherche Biomédicale (INRB) Democratic Republic of the Congo, the Institute of Tropical Medicine (ITM), Antwerp, and the Pandemic Sciences Institute at the University of Oxford.
Unlocking the full potential of community health workers for Africa’s adolescents
2 July 2026
New study identifies opportunities to strengthen adolescent health and well-being in Africa.
Smoking and drinking exacerbate social inequalities in premature deaths in India
25 June 2026
Study finds social inequality is a major predictor of premature death, even among people who neither smoke nor drink alcohol.
New analysis maps gaps in neglected tropical diseases clinical research
22 June 2026
Neglected tropical diseases (NTDs) affect more than one billion people, yet research activity is unevenly distributed. A new analysis has identified important clinical research gaps in NTDs, highlighting where greater research investment is needed to support the World Health Organization's goal of eliminating NTDs by 2030.
New Lancet review calls for urgent action to tackle the growing global threat of encephalitis
19 June 2026
The review highlights encephalitis as an urgent global health challenge and calling for faster diagnosis, improved treatments, and strengthened prevention strategies to reduce death and disability worldwide.
Drought linked to 46% increase in sexual violence among adolescents in Southern Africa
18 June 2026
Study reveals climate change is increasing risks to child safety.
Oxford Global Health Seminar Series: AI, Ethics and Global Health
18 June 2026
How can AI improve global health without reinforcing existing inequalities? The inaugural Oxford Global Health Seminar Series explored the opportunities, challenges and ethical dilemmas raised by AI in global health.
What do we mean by equity in global health?
15 June 2026
The first Medical Humanities-Global Health Glossary Workshop brought together researchers from across disciplines to explore one of global health's most frequently used - and contested - concepts: equity.
New Lancet series shows how thousands of maternal deaths could be prevented each year
12 June 2026
Every 12 minutes, somewhere in the world, a woman dies from excessive bleeding after birth (postpartum haemorrhage or PPH). Yet according to a new three-part Lancet Series, led by researchers from the University of Oxford, most of these deaths should never happen.
The Pan-African Pulse: A global health podcast
2 June 2026
The new Pan-African Pulse podcast brings together voices from across Africa to explore the geopolitical forces shaping health on the continent.
UK and France launch landmark biomedical and AI health alliance to accelerate research into major diseases
29 May 2026
A new partnership will unite expertise, infrastructure and data across borders to accelerate diagnosis, treatment and ultimately prevention of major diseases – starting with women’s health, infectious diseases and pandemic preparedness.
Decentralising disease surveillance and modelling approaches will support equitable infectious disease responses
29 May 2026
By sharing data analytics instead of raw data, federated approaches enable surveillance and modelling while respecting ethical and legal boundaries.
Wearable GPS data expands understanding of schistosomiasis transmission
22 May 2026
Proximity to unsafe water strongly predicts schistosomiasis exposure, explaining sharp differences in infection and re‑infection across communities.
Turning the tide on substandard and falsified medicines
20 May 2026
The Medicine Quality, Innovation & Policy Conference 2026 brought together global experts from science, law enforcement, public health and policy to address the growing threat of substandard and falsified medicines. Discussions highlighted the need for stronger international collaboration, better data sharing, improved detection technologies, and coordinated public health and regulatory responses to protect vulnerable populations from unsafe medical products.
Major study highlights promise of digital technology in improving hypertension care across sub-Saharan Africa
13 May 2026
A major international study published in BMJ Public Health has found that a digitally enabled healthcare programme was associated with significant improvements in blood pressure control among people living with hypertension across sub-Saharan Africa.
Professor Adrian Hill selected as a finalist for the European Inventor Award 2026
12 May 2026
The European Patent Office has named Professor Adrian Hill, Lakshmi Mittal Professor of Vaccinology and Director of the Jenner Institute at the University of Oxford, a finalist for the European Inventor Award 2026 for work leading to the R21/Matrix-M malaria vaccine, a major advance in efforts to reduce the global burden of malaria.
Solidarity: the word everyone uses, but few practise
7 May 2026
What does solidarity actually demand of global health when the system itself is under strain? This question gave the Global Health Solidarity Project’s 2026 Open Forum urgency, edge and relevance.
New study improves early detection of life-threatening infection in children across South and South East Asia
6 May 2026
A new study published in Nature Medicine suggests that simple, low-cost tools could help health workers identify children at risk of life-threatening infection earlier, improving access to urgent care in across South and South East Asia.
New study highlights promising non-invasive approach to endometriosis diagnosis and monitoring
29 April 2026
A new Oxford-led study highlights the potential of a molecular imaging agent used alongside non-invasive scanning to improve the diagnosis and monitoring of endometriosis - a condition affecting an estimated 190 million women worldwide where delayed diagnosis remains a significant women's health challenge.
New rabies vaccine could provide protection for adults and children with a single dose
29 April 2026
A new clinical trial led by researchers at the Jenner Institute in collaboration Ifakara Health Institute Tanzania, suggests that a single-dose rabies vaccine could provide safe, long-lasting protection in both adults and children. The research could lead to a simpler, lower-cost approach that could transform rabies prevention in high-risk regions.